CDC Identifies Contamination in More Medical Products From New England Compounding Center
The CDC has identified additional microbial contamination in unopened vials of betamethasone, cardioplegia and triamcinolone solutions that were distributed and recalled from NECC.
Clinicians should continue to report infections related to NECC products to FDA's MedWatch and state health departments.
Related Articles on ASC Medical Supplies:
Access MediQuip Names Patrick McCarthy Chief Network Development Officer
Volcano Corp. to Acquire Crux Biomedical
FDA Enters Partnership to Help Increase Access to New Medical Devices
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New From Becker's ASC Review
ePreop platform successfully submits QDCR data for anesthesiologists: 3 things to knowRead Now
- ASC Industry Leader to Know: Sarah Malaniak of Ambulatory Center for Endoscopy
- Affinity Health Plan bolsters executive team: 5 key points
- 10 trendy apps for ASC physicians
- The keys to financial success: How to keep ASCs profitable
- ASC success in the age of consumer responsibility: 3 thoughts on high deductible patients